- Home
- KRRO vs UCL Comparison
KRRO vs UCL Comparison
Compare KRRO & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- UCL
- Stock Information
- Founded
- KRRO 2014
- UCL 2014
- Country
- KRRO United States
- UCL Hong Kong
- Employees
- KRRO N/A
- UCL N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- KRRO Health Care
- UCL Consumer Discretionary
- Exchange
- KRRO Nasdaq
- UCL Nasdaq
- Market Cap
- KRRO 147.4M
- UCL 144.5M
- IPO Year
- KRRO 2019
- UCL 2020
- Fundamental
- Price
- KRRO $33.22
- UCL $2.49
- Analyst Decision
- KRRO Strong Buy
- UCL
- Analyst Count
- KRRO 7
- UCL 0
- Target Price
- KRRO $96.71
- UCL N/A
- AVG Volume (30 Days)
- KRRO 237.0K
- UCL 106.8K
- Earning Date
- KRRO 11-11-2025
- UCL 08-13-2025
- Dividend Yield
- KRRO N/A
- UCL N/A
- EPS Growth
- KRRO N/A
- UCL N/A
- EPS
- KRRO N/A
- UCL 0.02
- Revenue
- KRRO $6,281,000.00
- UCL $89,277,000.00
- Revenue This Year
- KRRO $97.27
- UCL N/A
- Revenue Next Year
- KRRO N/A
- UCL $20.86
- P/E Ratio
- KRRO N/A
- UCL $110.95
- Revenue Growth
- KRRO N/A
- UCL 3.72
- 52 Week Low
- KRRO $10.29
- UCL $0.80
- 52 Week High
- KRRO $98.00
- UCL $4.19
- Technical
- Relative Strength Index (RSI)
- KRRO 67.72
- UCL 50.75
- Support Level
- KRRO $30.36
- UCL $2.51
- Resistance Level
- KRRO $37.03
- UCL $3.20
- Average True Range (ATR)
- KRRO 3.68
- UCL 0.24
- MACD
- KRRO -0.07
- UCL -0.23
- Stochastic Oscillator
- KRRO 77.36
- UCL 69.17
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.